Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL823099 | 0.72 | CYP2C19 (0.38) | MAPK1ALDH1A1 | |
| SCHEMBL754497 | 0.72 | MAPK1 (0.36) | MAPK1ALDH1A1 | |
| SCHEMBL12433234 | 0.72 | MAPK1 (0.36) | MAPK1ALDH1A1 | |
| SCHEMBL6176534 | 0.70 | MAPK1 (0.40) | MAPK1ALDH1A1 | |
| SCHEMBL7298010 | 0.69 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL38182 | 0.69 | — | — | |
| SCHEMBL31207702 | 0.67 | TDP1 (0.35) | — | |
| SCHEMBL20725835 | 0.67 | — | — | |
| SCHEMBL25494690 | 0.67 | MAPK1 (0.33) | MAPK1ALDH1A1 | |
| SCHEMBL19543066 | 0.67 | MAPK1 (0.33) | MAPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3924361-B1 | NOVEL TRITERPENE DERIVATIVES AS HIV INHIBITORS | HETERO LABS LTD (IN) | 2023-09-06 | — | — | EP | claimed |
| US-9670350-B2 | Polymer dispersants | BASF SE (DE) | 2017-06-06 | — | — | US | disclosed |
| US-9497970-B2 | Pesticide compounds | BASF SE (DE) | 2016-11-22 | — | — | US | disclosed |
| US-9404002-B2 | Molecular precursor compounds for indium gallium zinc oxide materials | TRANSTRON SOLUTIONS LLC (US) | 2016-08-02 | — | — | US | disclosed |
| US-9404009-B2 | Polymer dispersants | BASF SE (DE) | 2016-08-02 | — | — | US | disclosed |
| US-20160157491-A1 | Pesticide Compounds | BASF SE (DE) | 2016-06-09 | — | — | US | disclosed |
| US-20160102198-A1 | NOVEL POLYMER DISPERSANTS | BASF SE (DE) | 2016-04-14 | — | — | US | disclosed |
| US-9174967-B2 | Substituted pyrazole-containing compounds and their use as pesticides | BASF SE (DE) | 2015-11-03 | — | — | US | disclosed |
| US-9169253-B2 | Tricyclic quinoline and quinoxaline derivatives | AbbVie Deutschland GmbH & Co. KG (DE) | 2015-10-27 | — | — | US | disclosed |
| US-9161894-B2 | Use of N-(4-methoxyphenyl)-1-phenyl-1H-pyrazol-3-amine and related compounds | NPHARMAKON, LLC (US) | 2015-10-20 | — | — | US | disclosed |
| US-20050272709-A1 | Immugenic compositions and diagnostic and therapeutic uses thereof | DERMIRA (CANADA), INC. | 2005-12-08 | — | — | US | disclosed |
| US-20050065163-A1 | Platelet adenosine diphosphate receptor antagonists | SCHERING AKTIENGESELLSCHAFT (DE) | 2005-03-24 | — | — | US | disclosed |
| US-20040171588-A1 | Cardioprotective phosphonates and malonates | MEDICURE INTERNATIONAL INC. (CA) | 2004-09-02 | — | — | US | disclosed |
| US-6677356-B1 | CONCURRENTLY ADMINISTERING PYRIDOXAL-5'-PHOSPHATE, PYRIDOXAMINE, PYRIDOXAL, OR A 3-ACYLATED PYRIDOXAL ANALOGUE WITH ANGIOTENSIN CONVERTING ENZYME INHIBITOR,CALCIUM CHANNEL BLOCKER, ADRENERGIC BLOCKING AGENT, VASODILATOR OR DIURETIC | MEDICURE INTERNATIONAL INC. (KY) | 2004-01-13 | — | — | US | disclosed |
| US-6676926-B2 | FOR ADMINISTERING TO A HUMAN IN NEED OF SUCH DIAGNOSIS AND MEASURING THE RADIOACTIVITY ARISING FROM THE ADMINISTRATION OF THE COMPOUND TO THE HUMAN EITHER BY USING A GAMMA CAMERA OR BY POSITRON EMISSION TOMOGRAPHY | SCHERING AKTIENGESELLSCHAFT (DE) | 2004-01-13 | — | — | US | disclosed |
| EP-0920430-B1 | PURINE DERIVATIVES AND THEIR USE AS ANTI-COAGULANTS | SCHERING AG (DE) | 2003-09-24 | — | — | EP | disclosed |
| US-20020165218-A1 | Materials and methods to potentiate cancer treatment | LUITPOLD PHARMACEUTICALS, INC. | 2002-11-07 | — | — | US | disclosed |
| US-20020131932-A1 | Radiopharmaceuticals for diagnosing alzheimer's disease | SCHERING AG (DE) | 2002-09-19 | — | — | US | disclosed |
| CN-1272841-A | Novel lactam metalloprotease inhibitors | DU PONT PHARM CO (US) | 2000-11-08 | — | — | CN | disclosed |
| CN-1067241-A | The method of terminal olefin oxidation system aldehyde | UNION CARBIDE CHEM PLASTIC (US) | 1992-12-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160157491-A1 | Pesticide Compounds | C1R, C1S, CBR3 | MAPK1 2362/4885ALDH1A1 2336/4885 |
| US-20050065163-A1 | Platelet adenosine diphosphate receptor antagonists | ADORA2B, ADORA1, TBXA2R | MAPK1 2811/4885ALDH1A1 745/4885 |
| US-20050272709-A1 | Immugenic compositions and diagnostic and therapeutic uses thereof | MKI67, CDK4, CCNC | MAPK1 1293/4885ALDH1A1 3393/4885 |
| US-20020131932-A1 | Radiopharmaceuticals for diagnosing alzheimer's disease | CCR1, CCR3, CCR2 | MAPK1 2953/4885ALDH1A1 852/4885 |
| US-20020165218-A1 | Materials and methods to potentiate cancer treatment | DCK, CHEK2, CHEK1 | MAPK1 1347/4885ALDH1A1 3519/4885 |
| US-20040171588-A1 | Cardioprotective phosphonates and malonates | PRDX5, FABP3, PRDX6 | MAPK1 1542/4885ALDH1A1 1489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.